Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2021-01-22 | 2021-09-02 | 132261 |
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2021-04-29 | 2021-08-24 | 138320 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Resolved | 2021-07-08 | 2021-08-24 | 142204 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Resolved | 2021-07-08 | 2021-08-24 | 142189 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144448 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144451 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144454 |
| TEVA-SILDENAFIL | 50MG | TABLET | Resolved | 2021-08-05 | 2021-08-13 | 143725 |
| TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2021-07-29 | 2021-08-13 | 143246 |
| TEVA-ATENOLOL | 100MG | TABLET | Resolved | 2021-07-22 | 2021-08-13 | 142899 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2021-07-15 | 2021-08-13 | 142625 |
| TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-07-15 | 2021-08-13 | 142613 |
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2021-07-08 | 2021-08-13 | 142207 |
| TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2021-06-24 | 2021-08-13 | 141477 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-05-20 | 2021-08-13 | 139737 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Resolved | 2021-03-18 | 2021-08-13 | 135968 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2021-04-29 | 2021-08-07 | 138291 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2021-05-27 | 2021-08-06 | 140045 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2021-05-27 | 2021-08-06 | 140036 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2021-05-27 | 2021-08-06 | 140033 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |